The in-vitro activity of pristinamycin against Haemophilus influenzae and Neisseria meningitidis.
The in-vitro activity of erythromycin, oleandomycin, spiramycin, josamycin and pristinamycin was tested by a plate-dilution method against strains of Haemophilus influenzae and Neisseria meningitidis. Pristinamycin was the most active product tested with minimal inhibitory concentrations (MIC) ranging between 0.5 and 4 mg/l for H. influenzae (modal value 1 mg/l) and between 0.03 and 0.12 mg/l for N. meningitidis (modal value 0.06 mg/l).
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D006193:Haemophilus influenzae / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D009345:Neisseria meningitidis / Q000187:drug effects*; D010455:Peptides / Q000494:pharmacology; D013045:Species Specificity; D013329:Structure-Activity Relationship; D014769:Virginiamycin
D000900:Anti-Bacterial Agents; D010455:Peptides; D014769:Virginiamycin